Literature DB >> 15652475

P53 and prognosis: new insights and further complexity.

Karen H Vousden1, Carol Prives.   

Abstract

Despite the massive amount of knowledge that has accumulated about p53, there is still much to learn about its role in tumor suppression. New papers now provide evidence that levels of Mdm2 in humans or presence of mutant forms of p53 in mice can have profound impacts on survival and tumorigenesis. These findings may lead to new diagnostic and therapeutic approaches to treating cancer patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15652475     DOI: 10.1016/j.cell.2004.12.027

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  93 in total

1.  A novel loss-of-function mutation in TP53 in an endometrial cancer cell line and uterine papillary serous carcinoma model.

Authors:  Zhihe Liu; Guanghua Wan; Christopher Heaphy; Marco Bisoffi; Jeffrey K Griffith; Chien-An A Hu
Journal:  Mol Cell Biochem       Date:  2006-11-21       Impact factor: 3.396

2.  Expression of the Bcl-3 proto-oncogene suppresses p53 activation.

Authors:  David Kashatus; Patricia Cogswell; Albert S Baldwin
Journal:  Genes Dev       Date:  2005-12-29       Impact factor: 11.361

3.  The tumor suppressor protein p53 is required for neurite outgrowth and axon regeneration.

Authors:  Simone Di Giovanni; Chad D Knights; Mahadev Rao; Alexander Yakovlev; Jeannette Beers; Jason Catania; Maria Laura Avantaggiati; Alan I Faden
Journal:  EMBO J       Date:  2006-08-31       Impact factor: 11.598

4.  p53 initiates apoptosis by transcriptionally targeting the antiapoptotic protein ARC.

Authors:  Yu-Zhen Li; Dao-Yuan Lu; Wei-Qi Tan; Jian-Xun Wang; Pei-Feng Li
Journal:  Mol Cell Biol       Date:  2007-11-12       Impact factor: 4.272

5.  Synergistic roles of Mdm2 and Mdm4 for p53 inhibition in central nervous system development.

Authors:  Shunbin Xiong; Carolyn S Van Pelt; Ana C Elizondo-Fraire; Geng Liu; Guillermina Lozano
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

6.  miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42.

Authors:  Seong-Yeon Park; Jung Hyun Lee; Minju Ha; Jin-Wu Nam; V Narry Kim
Journal:  Nat Struct Mol Biol       Date:  2008-12-14       Impact factor: 15.369

Review 7.  Immunohistochemistry in diagnostic surgical pathology: contributions of protein life-cycle, use of evidence-based methods and data normalization on interpretation of immunohistochemical stains.

Authors:  Halliday A Idikio
Journal:  Int J Clin Exp Pathol       Date:  2009-11-25

8.  Induction of SOX4 by DNA damage is critical for p53 stabilization and function.

Authors:  Xin Pan; Jie Zhao; Wei-Na Zhang; Hui-Yan Li; Rui Mu; Tao Zhou; Hai-Ying Zhang; Wei-Li Gong; Ming Yu; Jiang-Hong Man; Pei-Jing Zhang; Ai-Ling Li; Xue-Min Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-20       Impact factor: 11.205

9.  Recognition of RNA by the p53 tumor suppressor protein in the yeast three-hybrid system.

Authors:  Kasandra J-L Riley; Laura A Cassiday; Akash Kumar; L James Maher
Journal:  RNA       Date:  2006-04       Impact factor: 4.942

10.  Killin is a p53-regulated nuclear inhibitor of DNA synthesis.

Authors:  Yong-Jig Cho; Peng Liang
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.